Evidence map›Paper›PMID 23642707›Full record

ReviewTrends in neurosciences2013

Where no synapses go: gatekeepers of circuit remodeling and synaptic strength.

Yevgeniya A Mironova, Roman J Giger

Open access · greenAbstract readReview
In one paragraph

Review in Trends in neurosciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yevgeniya A MironovaDepartment of Cell and Developmental Biology, University of Michigan School of Medicine, 3065 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA.
Roman J Giger
University of Michigan–Ann Arbor · US

Funding

CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
INTERDEPARTMENTAL NEUROSCIENCE TRAININGT32NS007489 · NINDS · UNIVERSITY OF ROCHESTER · PI OLSCHOWKA, JOHN A · 2000 to 2014
$3.4M
Neuronal regulation of myelinationR01NS081281 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIGER, ROMAN JENO · 2012 to 2016
$1.7M
NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32-GM007315NINDS NIH HHS R01 NS081281NINDS NIH HHS T32 NS007489
6 · The paper itself

Abstract

Growth inhibitory molecules in the adult mammalian central nervous system (CNS) have been implicated in the blocking of axonal sprouting and regeneration following injury. Prominent CNS regeneration inhibitors include Nogo-A, oligodendrocyte myelin glycoprotein (OMgp), and chondroitin sulfate proteoglycans (CSPGs), and a key question concerns their physiological role in the naïve CNS. Emerging evidence suggests novel functions in dendrites and at synapses of glutamatergic neurons. CNS regeneration inhibitors target the neuronal actin cytoskeleton to regulate dendritic spine maturation, long-term synapse stability, and Hebbian forms of synaptic plasticity. This is accomplished in part by antagonizing plasticity-promoting signaling pathways activated by neurotrophic factors. Altered function of CNS regeneration inhibitors is associated with mental illness and loss of long-lasting memory, suggesting unexpected and novel physiological roles for these molecules in brain health.

Indexed as

AmnesiaAnimalsAstrocytesBrainBrain InjuriesChondroitin Sulfate ProteoglycansCytoskeletonDendritesDominance, OcularGlycosaminoglycansGPI-Linked ProteinsHumansMental DisordersMiceModels, NeurologicalMyelin ProteinsChondroitin Sulfate ProteoglycansGlycosaminoglycansGPI-Linked ProteinsMyelin ProteinsNerve Tissue ProteinsNogo ProteinsNogo Receptor 1OMG protein, humanReceptors, Cell SurfaceRTN4 protein, humanRtn4 protein, mouseRTN4R protein, human

Identifiers

PMID23642707
PMCPMC3674226
OpenAlexW2045592907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.